Pennsylvanias Medicaid spending for GLP-1s like Ozempic, Wegovy, and Zepbound exploded to an estimated $1.3 billion last year from $233 million in 2022, the year before Medicaid started covering the drugs for obesity
Published pricing lists compounded semaglutide from $129 first month under a 3-month plan and compounded tirzepatide from $249 first month
For general weight loss, GLP-1 and GIP/GLP-1 medications such as semaglutide and tirzepatide are more effective
For example, the individual beginning the peptide therapy may find that morning grogginess goes away or that they are able to make it through a gym session that they would normally be exhausted from
Nausea and other side effects commonly improve within 4 to 8 weeks as your body adjusts, and often flare again briefly after each dose increase
The careful dose escalation that got you to your current level needs to happen again